Department of Physiology, School of Medicine, University of Kentucky Medical Center, 800 Rose Street, Lexington, KY 40536-0298, USA.
J Mol Histol. 2013 Apr;44(2):191-201. doi: 10.1007/s10735-012-9457-4. Epub 2013 Feb 7.
Osteoarthritis is a degenerative joint disease mostly occurring in the knee and commonly seen in middle-aged and elderly adults. Intra-articular injection of hyaluronic acid has been widely used for treatment of knee osteoarthritis. The aim of this study was to evaluate the efficacy of intra-articular injection of a novel highly cross-linked hyaluronic acid, alone or in combination with ropivacaine hydrochloride and triamcinolone acetonide, on knee articular cartilage in a rabbit model of collagenase-induced knee osteoarthritis. After induction of experimental osteoarthritis by intra-articular injection of collagenase, adult New Zealand white rabbits (n = 12) were divided into 3 groups. Group 1 (control group) received 0.3 ml phosphate buffered saline into the right knee joint. Group 2 received 0.3 ml cross-linked hyaluronic acid (33 mg/ml) into the right knee joint. Group 3 received a mixture of 0.15 ml cross-linked hyaluronic acid (33 mg/ml), 0.05 ml ropivacaine hydrochloride 1 % and 0.1 ml triamcinolone acetonide (10 mg/ml) into the right knee joint. Intra-articular injections were given 4 weeks after first collagenase injection and were administered once a week for 3 weeks. Gross pathology and histological evaluation of rabbits' knee joints were performed after 16 weeks following initial collagenase injection. Histological analysis of sections of right knee joints at lesion sites showed a significant decrease in Mankin's score in groups treated with hyaluronic acid alone or in combination with ropivacaine hydrochloride and triamcinolone acetonide versus control group (p < 0.05 and p < 0.01 respectively). This evidence was consistent with strong articular degenerative changes in control right knee joints (grade III osteoarthritis), while the treated groups revealed less severe articular degenerative changes (grade II osteoarthritis). The present results show that cross-linked hyaluronic acid, alone or in combination with ropivacaine hydrochloride and triamcinolone acetonide, produces a significant improvement in knee articular cartilage degeneration in a rabbit model of collagenase-induced osteoarthritis.
骨关节炎是一种退行性关节疾病,主要发生在膝关节,常见于中老年人。关节内注射透明质酸已广泛用于治疗膝骨关节炎。本研究旨在评估新型高度交联透明质酸单独或与盐酸罗哌卡因和曲安奈德联合应用于胶原酶诱导的兔膝骨关节炎模型中膝关节软骨的疗效。通过关节内注射胶原酶诱导实验性骨关节炎后,将 12 只成年新西兰白兔分为 3 组。第 1 组(对照组)右膝关节内注射 0.3ml 磷酸盐缓冲液。第 2 组右膝关节内注射 0.3ml 交联透明质酸(33mg/ml)。第 3 组右膝关节内注射 0.15ml 交联透明质酸(33mg/ml)、0.05ml 1%盐酸罗哌卡因和 0.1ml 曲安奈德(10mg/ml)混合物。首次注射胶原酶后 4 周开始关节内注射,每周 1 次,共 3 周。首次胶原酶注射后 16 周对兔膝关节进行大体病理和组织学评价。右膝关节病变部位组织学分析显示,单独使用透明质酸或与盐酸罗哌卡因和曲安奈德联合使用治疗组的 Mankin 评分明显低于对照组(分别为 p<0.05 和 p<0.01)。这一证据与对照组右膝关节(III 级骨关节炎)出现的严重关节退行性改变一致,而治疗组的关节退行性改变较轻(II 级骨关节炎)。本研究结果表明,交联透明质酸单独或与盐酸罗哌卡因和曲安奈德联合应用可显著改善胶原酶诱导的兔膝骨关节炎模型中膝关节软骨退变。